Optimal left ventricular endocardial pacing sites for cardiac resynchronization therapy in patients with ischemic

David D Spragg1, Jun Dong, Barry J Fetics

  • 1Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA. dspragg1@jhmi.edu

Insights

Optimizing cardiac resynchronization therapy (CRT) in ischemic cardiomyopathy (ICM) requires individualizing left ventricular (LV) endocardial pacing sites. Best LV endocardial pacing improves mechanical response more than standard CRT.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Management

Background:

  • Cardiac resynchronization therapy (CRT) improves outcomes in heart failure but response varies, especially in ischemic cardiomyopathy (ICM).
  • Endocardial biventricular (BiV) pacing offers potential for optimized left ventricular (LV) lead placement.
  • Optimal LV endocardial pacing sites in ICM patients remain largely undefined.

Purpose of the Study:

  • To investigate the impact of specific LV pacing sites on mechanical response to CRT in patients with ICM.
  • To determine if endocardial BiV pacing can improve CRT efficacy compared to standard pacing in ICM.

Main Methods:

  • Measured peak rate of LV pressure increase (dP/dt(max)) during VDD and BiV pacing at various LV endocardial sites in 11 ICM patients.
  • Utilized electroanatomic mapping to identify optimal pacing regions achieving >=85% of maximal dP/dt(max).
  • Compared endocardial pacing with existing epicardial CRT leads in 7 patients.

Main Results:

  • Endocardial BiV pacing significantly improved dP/dt(max) compared to right ventricular apex pacing (241 +/- 38 mm Hg/s increase).
  • The best LV endocardial pacing site yielded superior dP/dt(max) compared to pre-implanted epicardial CRT leads (111 +/- 25 mm Hg/s increase).
  • Optimal sites varied individually, often located in basal lateral walls, remote from infarct zones; standard mid-LV pacing was suboptimal in 73%.

Conclusions:

  • Best LV endocardial pacing sites enhance CRT effectiveness in ICM patients beyond standard coronary sinus lead placement.
  • Patient-specific LV endocardial pacing site selection is crucial for optimizing CRT outcomes in ICM.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.